Breaking News - The Fly

Open Search

RHHBY

Roche

$

()

FDA approves Genentech's Alecensa for adjuvant treatment

RHHBY

4/18/2024 - 16:36pm

Roche announces data from its Phase III OCARINA II study of OCREVUS

RHHBY

4/17/2024 - 06:17am

Genentech reports data from OCARINA II study of Ocrevus

RHHBY

4/17/2024 - 05:20am

Roche price target raised by CHF 10 at Morgan Stanley

RHHBY

4/16/2024 - 13:51pm

Fresenius SE launches biosimilar of Roche's Actemra

FSNUY , RHHBY

4/15/2024 - 12:32pm

Genentech announces STARGLO study meets primary endpoint

RHHBY

4/15/2024 - 05:15am

Roche announces U.S. FDA granted BDD to its Elecsys pTau217 assay

RHHBY , LLY

4/11/2024 - 06:17am

Roche announces CE Mark for Ventana HER2 Rabbit Monoclonal Primary RxDx

RHHBY , AZN

4/10/2024 - 05:23am

Roche just upgraded at Kepler Cheuvreux, here's why

RHHBY

4/9/2024 - 05:22am

Roche receives FDA approval for molecular test to screen blood donors for malaria

RHHBY

3/26/2024 - 12:56pm

Roche’s mixed myasthenia gravis data sending these stocks in opposite directions

RHHBY , TRML , ARGX

…

3/21/2024 - 10:54am

Tourmaline Bio might see weakness today after Roche MG data, says Truist

TRML , RHHBY , IMVT

…

3/21/2024 - 08:18am

Immunovant rallies after Chugai myasthenia gravis study failure

IMVT , RHHBY , ARGX

3/21/2024 - 08:12am

Tourmaline Bio sinks after Chugai myasthenia gravis study failure

TRML , RHHBY

3/21/2024 - 08:11am

Argenx rallies after Chugai generalized myasthenia gravis study fails

ARGX , RHHBY

3/21/2024 - 07:15am